Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 7/2013

01-07-2013 | Magnetic Resonance

Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?

Authors: Peter S. N. van Rossum, Richard van Hillegersberg, Frederiek M. Lever, Irene M. Lips, Astrid L. H. M. W. van Lier, Gert J. Meijer, Maarten S. van Leeuwen, Marco van Vulpen, Jelle P. Ruurda

Published in: European Radiology | Issue 7/2013

Login to get access

Abstract

Objectives

To outline the current role and future potential of magnetic resonance imaging (MRI) in the management of oesophageal cancer regarding T-staging, N-staging, tumour delineation for radiotherapy (RT) and treatment response assessment.

Methods

PubMed, Embase and the Cochrane library were searched identifying all articles related to the use of MRI in oesophageal cancer. Data regarding the value of MRI in the areas of interest were extracted in order to calculate sensitivity, specificity, predictive values and accuracy for group-related outcome measures.

Results

Although historically poor, recent improvements in MRI protocols and techniques have resulted in better imaging quality and the valuable addition of functional information. In recent studies, similar or even better results have been achieved using optimised MRI compared with other imaging strategies for T- and N-staging. No studies clearly report on the role of MRI in oesophageal tumour delineation and real-time guidance for RT so far. Recent pilot studies showed that functional MRI might be capable of predicting pathological response to treatment and patient prognosis.

Conclusions

In the near future MRI has the potential to bring improvement in staging, tumour delineation and real-time guidance for RT and assessment of treatment response, thereby complementing the limitations of currently used imaging strategies.

Key Points

• MRI’s role in oesophageal cancer has been somewhat limited to date.
• However MRI’s ability to depict oesophageal cancer is continuously improving.
• Optimising TN-staging, radiotherapy planning and response assessment ultimately improves individualised cancer care.
• MRI potentially complements the limitations of other imaging strategies regarding these points.
Literature
1.
2.
van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084PubMedCrossRef
3.
Kumbasar B (2002) Carcinoma of esophagus: radiologic diagnosis and staging. Eur J Radiol 42:170–180PubMedCrossRef
4.
5.
Wu LF, Wang BZ, Feng JL et al (2003) Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol 9:219–224PubMed
6.
Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: 5-year survival of a randomized clinical trial. Ann Surg 246:992–1000, discussion 1000–1PubMedCrossRef
7.
Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234PubMedCrossRef
8.
Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12:681–692PubMedCrossRef
9.
10.
Koch J, Halvorsen RA Jr (1994) Staging of esophageal cancer: computed tomography, magnetic resonance imaging, and endoscopic ultrasound. Semin Roentgenol 29:364–372PubMedCrossRef
11.
12.
Jamil LH, Gill KR, Wallace MB (2008) Staging and restaging of advanced esophageal cancer. Curr Opin Gastroenterol 24:530–534PubMedCrossRef
13.
Kim TJ, Kim HY, Lee KW, Kim MS (2009) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29:403–421PubMedCrossRef
14.
Nishimura Y, Osugi H, Inoue K, Takada N, Takamura M, Kinosita H (2002) Bronchoscopic ultrasonography in the diagnosis of tracheobronchial invasion of esophageal cancer. J Ultrasound Med 21:49–58PubMed
15.
Rasanen JV, Sihvo EI, Knuuti MJ et al (2003) Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 10:954–960PubMedCrossRef
16.
Smyth EC, Shah MA (2011) Role of (F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol 17:5059–5074PubMedCrossRef
17.
Pfau PR, Perlman SB, Stanko P et al (2007) The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc 65:377–384PubMedCrossRef
18.
Munden RF, Macapinlac HA, Erasmus JJ (2006) Esophageal cancer: the role of integrated CT-PET in initial staging and response assessment after preoperative therapy. J Thorac Imaging 21:137–145PubMedCrossRef
19.
Bruzzi JF, Truong MT, Macapinlac H, Munden RF, Erasmus JJ (2007) Integrated CT-PET imaging of esophageal cancer: unexpected and unusual distribution of distant organ metastases. Curr Probl Diagn Radiol 36:21–29PubMedCrossRef
20.
21.
Quint LE, Glazer GM, Orringer MB (1985) Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology 156:727–731PubMed
22.
Takashima S, Takeuchi N, Shiozaki H et al (1991) Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol 156:297–302PubMedCrossRef
23.
Chang EY, Li X, Jerosch-Herold M et al (2008) The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging. J Gastrointest Surg 12:166–175PubMedCrossRef
24.
Oberholzer K, Pohlmann A, Schreiber W et al (2008) Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 27:1296–1301PubMedCrossRef
25.
Sakurada A, Takahara T, Kwee TC et al (2009) Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19:1461–1469PubMedCrossRef
26.
Aoyagi T, Shuto K, Okazumi S et al (2010) Evaluation of the clinical staging of esophageal cancer by using diffusion-weighted imaging. Exp Ther Med 1:847–851
27.
Aoyagi T, Shuto K, Okazumi S, Shimada H, Kazama T, Matsubara H (2011) Apparent diffusion coefficient values measured by diffusion-weighted imaging predict chemoradiotherapeutic effect for advanced esophageal cancer. Dig Surg 28:252–257PubMedCrossRef
28.
Yamada I, Izumi Y, Kawano T et al (2006) Esophageal carcinoma: evaluation with high-resolution three-dimensional constructive interference in steady state MR imaging in vitro. J Magn Reson Imaging 24:1326–1332PubMedCrossRef
29.
Rice TW, Rusch VW, Ishwaran H, Blackstone EH, Worldwide Esophageal Cancer Collaboration (2010) Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer staging manuals. Cancer 116:3763–3773PubMedCrossRef
30.
Edge S, Byrd D, Compton C (2010) AJCC cancer staging manual, 7th edn. Springer, New York, pp 103–115
31.
Talsma K, van Hagen P, Grotenhuis BA et al (2012) Comparison of the 6th and 7th editions of the UICC-AJCC TNM classification for esophageal cancer. Ann Surg Oncol 19:2142–2148PubMedCrossRef
32.
Ajani JA, Barthel JS, Bentrem DJ et al (2011) Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw 9:830–887
33.
34.
Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14:1479–1490PubMedCrossRef
35.
van Vliet EP, Eijkemans MJ, Kuipers EJ, Poley JW, Steyerberg EW, Siersema PD (2007) Publication bias does not play a role in the reporting of the results of endoscopic ultrasound staging of upper gastrointestinal cancers. Endoscopy 39:325–332PubMedCrossRef
36.
Preston SR, Clark GW, Martin IG, Ling HM, Harris KM (2003) Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma. Br J Surg 90:1220–1224PubMedCrossRef
37.
Wakelin SJ, Deans C, Crofts TJ, Allan PL, Plevris JN, Paterson-Brown S (2002) A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 41:161–167PubMedCrossRef
38.
van Vliet EP, Eijkemans MJ, Poley JW, Steyerberg EW, Kuipers EJ, Siersema PD (2006) Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc 63:938–947PubMedCrossRef
39.
Kelly S, Harris KM, Berry E et al (2001) A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49:534–539PubMedCrossRef
40.
Rice TW (2000) Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 10:471–485PubMed
41.
Wayman J, Chakraverty S, Griffin SM, Doyle GJ, Keir MJ, Simpson W (2001) Evaluation of local invasion by oesophageal carcinoma–a prospective study of prone computed tomography scanning. Postgrad Med J 77:181–184PubMedCrossRef
42.
van Zoonen M, van Oijen MG, van Leeuwen MS, van Hillegersberg R, Siersema PD, Vleggaar FP (2012) Low impact of staging EUS for determining surgical resectability in esophageal cancer. Surg Endosc 26:2828–2834PubMedCrossRef
43.
Lehr L, Rupp N, Siewert JR (1988) Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery 103:344–350PubMed
44.
Osugi H, Nishimura Y, Takemura M et al (2003) Bronchoscopic ultrasonography for staging supracarinal esophageal squamous cell carcinoma: impact on outcome. World J Surg 27:590–594PubMedCrossRef
45.
Wakamatsu T, Tsushima K, Yasuo M et al (2006) Usefulness of preoperative endobronchial ultrasound for airway invasion around the trachea: esophageal cancer and thyroid cancer. Respiration 73:651–657PubMedCrossRef
46.
Garrido T, Maluf-Filho F, Sallum RA, Figueiredo VR, Jacomelli M, Tedde M (2009) Endobronchial ultrasound application for diagnosis of tracheobronchial tree invasion by esophageal cancer. Clinics (Sao Paulo) 64:499–504CrossRef
47.
Omloo JM, van Heijl M, Bergman JJ, Koolen MG, van Berge Henegouwen MI, van Lanschot JJ (2008) Value of bronchoscopy after EUS in the preoperative assessment of patients with esophageal cancer at or above the carina. J Gastrointest Surg 12:1874–1879PubMedCrossRef
48.
Petrillo R, Balzarini L, Bidoli P et al (1990) Esophageal squamous cell carcinoma: MRI evaluation of mediastinum. Gastrointest Radiol 15:275–278PubMedCrossRef
49.
Nakashima A, Nakashima K, Seto H et al (1997) Thoracic esophageal carcinoma: evaluation in the sagittal section with magnetic resonance imaging. Abdom Imaging 22:20–23PubMedCrossRef
50.
Riddell AM, Allum WH, Thompson JN, Wotherspoon AC, Richardson C, Brown G (2007) The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation. Eur Radiol 17:391–399PubMedCrossRef
51.
Kayani B, Zacharakis E, Ahmed K, Hanna GB (2011) Lymph node metastases and prognosis in oesophageal carcinoma–a systematic review. Eur J Surg Oncol 37:747–753PubMedCrossRef
52.
Waterman TA, Hagen JA, Peters JH, DeMeester SR, Taylor CR, Demeester TR (2004) The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg 78:1161–1169, discussion 1161–9PubMedCrossRef
53.
Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, Van Cleynenbreughel B (1994) Advanced esophageal carcinoma. World J Surg 18:379–387PubMedCrossRef
54.
Eloubeidi MA, Wallace MB, Reed CE et al (2001) The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 54:714–719PubMedCrossRef
55.
Vazquez-Sequeiros E, Norton ID, Clain JE et al (2001) Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 53:751–757PubMedCrossRef
56.
van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD (2008) Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98:547–557PubMedCrossRef
57.
Salminen JT, Farkkila MA, Ramo OJ et al (1999) Endoscopic ultrasonography in the preoperative staging of adenocarcinoma of the distal oesophagus and oesophagogastric junction. Scand J Gastroenterol 34:1178–1182PubMedCrossRef
58.
Luketich JD, Schauer P, Landreneau R et al (1997) Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 114:817–821, discussion 821–3PubMedCrossRef
59.
van Westreenen HL, Westerterp M, Bossuyt PM et al (2004) Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805–3812PubMedCrossRef
60.
Mizowaki T, Nishimura Y, Shimada Y et al (1996) Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: evaluation by computed tomography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 36:1091–1098PubMedCrossRef
61.
Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I (2006) Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg 202:604–611PubMedCrossRef
62.
Alper F, Turkyilmaz A, Kurtcan S et al (2011) Effectiveness of the STIR turbo spin-echo sequence MR imaging in evaluation of lymphadenopathy in esophageal cancer. Eur J Radiol 80:625–628PubMedCrossRef
63.
Berger B, Belka C (2009) Evidence-based radiation oncology: oesophagus. Radiother Oncol 92:276–290PubMedCrossRef
64.
Njeh CF (2008) Tumor delineation: the weakest link in the search for accuracy in radiotherapy. J Med Phys 33:136–140PubMedCrossRef
65.
Sillah K, Williams LR, Laasch HU et al (2010) Computed tomography overestimation of esophageal tumor length: implications for radiotherapy planning. World J Gastrointest Oncol 2:197–204PubMedCrossRef
66.
Gao XS, Qiao X, Wu F et al (2007) Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67:389–396PubMedCrossRef
67.
Whitfield GA, Jackson A, Moore C, Price P (2008) Radical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use? Br J Radiol 81:921–934PubMedCrossRef
68.
Konski A, Doss M, Milestone B et al (2005) The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61:1123–1128PubMedCrossRef
69.
Thomas E, Crellin A, Harris K, Swift S, Montefiore DS (2004) The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer. Radiother Oncol 73:149–151PubMedCrossRef
70.
Button MR, Morgan CA, Croydon ES, Roberts SA, Crosby TD (2009) Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 73:818–823PubMedCrossRef
71.
Lambrecht M, Haustermans K (2010) Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors. Radiother Oncol 96:339–346PubMedCrossRef
72.
Muijs CT, Beukema JC, Pruim J et al (2010) A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 97:165–171PubMedCrossRef
73.
Rasch C, Steenbakkers R, van Herk M (2005) Target definition in prostate, head, and neck. Semin Radiat Oncol 15:136–145PubMedCrossRef
74.
75.
Groenendaal G, Borren A, Moman MR et al (2012) Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. Int J Radiat Oncol Biol Phys 82:e537–e544PubMedCrossRef
76.
Wang B, Kwon A, Zhu Y, Yeo I, Henson CF (2009) Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: a single institutional experience with three-dimensional CT-based planning. Brachytherapy 8:240–247PubMedCrossRef
77.
Hawkins MA, Bedford JL, Warrington AP, Tait DM (2012) Volumetric modulated arc therapy planning for distal oesophageal malignancies. Br J Radiol 85:44–52PubMedCrossRef
78.
Han C, Schiffner DC, Schultheiss TE, Chen YJ, Liu A, Wong JY (2012) Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer. Radiother Oncol 102:309–314PubMedCrossRef
79.
Kerkhof EM, Raaymakers BW, van der Heide UA, van de Bunt L, Jurgenliemk-Schulz IM, Lagendijk JJ (2008) Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study. Radiother Oncol 88:241–249PubMedCrossRef
80.
Lagendijk JJ, Raaymakers BW, Raaijmakers AJ et al (2008) MRI/linac integration. Radiother Oncol 86:25–29PubMedCrossRef
81.
Raaymakers BW, Lagendijk JJ, Overweg J et al (2009) Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept. Phys Med Biol 54:N229–N237PubMedCrossRef
82.
Boonstra JJ, Kok TC, Wijnhoven BP et al (2011) Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer 11:181PubMedCrossRef
83.
Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH (2009) Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol 15:5983–5991PubMedCrossRef
84.
Wijnhoven BP, van Lanschot JJ, Tilanus HW, Steyerberg EW, van der Gaast A (2009) Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses. World J Surg 33:2606–2614PubMedCrossRef
85.
van Heijl M, Omloo JM, van Berge Henegouwen MI et al (2011) Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg 253:56–63PubMedCrossRef
86.
Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313PubMed
87.
Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL (2005) Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 103:1791–1799PubMedCrossRef
88.
Habr-Gama A, Perez RO, Sao Juliao GP, Proscurshim I, Gama-Rodrigues J (2011) Nonoperative approaches to rectal cancer: a critical evaluation. Semin Radiat Oncol 21:234–239PubMedCrossRef
89.
Westerterp M, van Westreenen HL, Reitsma JB et al (2005) Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy–systematic review. Radiology 236:841–851PubMedCrossRef
90.
Ngamruengphong S, Sharma VK, Nguyen B, Das A (2010) Assessment of response to neoadjuvant therapy in esophageal cancer: an updated systematic review of diagnostic accuracy of endoscopic ultrasonography and fluorodeoxyglucose positron emission tomography. Dis Esophagus 23:216–231PubMedCrossRef
91.
Zuccaro G Jr, Rice TW, Goldblum J et al (1999) Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 94:906–912PubMedCrossRef
92.
Flamen P, Van Cutsem E, Lerut A et al (2002) Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13:361–368PubMedCrossRef
93.
van Heijl M, Phoa SS, van Berge Henegouwen MI et al (2011) Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer. Eur J Surg Oncol 37:1064–1071PubMedCrossRef
94.
Lambrecht M, Vandecaveye V, De Keyzer F et al (2012) Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 82:863–870PubMedCrossRef
95.
Verstraete KL, Van der Woude HJ, Hogendoorn PC, De-Deene Y, Kunnen M, Bloem JL (1996) Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 6:311–321PubMedCrossRef
96.
Ferraris R, Del Piano A, Galli JJ (2001) Role of magnetic resonance imaging in the staging of gastrointestinal neoplasms. Semin Surg Oncol 20:122–129PubMedCrossRef
97.
Pavone P, Cardone GP, Di Girolamo M et al (1992) Magnetic resonance imaging of the esophagus with lumen opacification using a specific contrast agent. Radiol Med 84:756–760PubMed
98.
Shuto K, Saito H, Ohira G et al (2009) Diffusion-weighted MR imaging for postoperative nodal recurrence of esophageal squamous cell cancer in comparison with FDG-PET. Gan To Kagaku Ryoho 36:2468–2470PubMed
99.
Tateishi U, Miyake M, Nagaoka T et al (2012) Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging–prospective assessment. Radiology 263:53–63PubMedCrossRef
100.
Cho YB, Chun HK, Kim MJ et al (2009) Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer. World J Surg 33:2688–2694PubMedCrossRef
101.
Kikuchi M, Shinohara S, Nakamoto Y et al (2011) Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma. Mol Imaging Biol 13:368–377PubMedCrossRef
Metadata
Title
Imaging strategies in the management of oesophageal cancer: what’s the role of MRI?
Authors
Peter S. N. van Rossum
Richard van Hillegersberg
Frederiek M. Lever
Irene M. Lips
Astrid L. H. M. W. van Lier
Gert J. Meijer
Maarten S. van Leeuwen
Marco van Vulpen
Jelle P. Ruurda
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
European Radiology / Issue 7/2013
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2773-6

Other articles of this Issue 7/2013

European Radiology 7/2013 Go to the issue

Gastrointestinal

Added value of ultrasound re-evaluation for patients with equivocal CT findings of acute appendicitis: a preliminary study

Oncology

MRI for response assessment in metastatic bone disease

Computed Tomography

“Dynamic spot sign” on CT perfusion source images predicts haematoma expansion in acute intracerebral haemorrhage

Interventional

Ultrasound-guided core-needle biopsy of extra-ocular orbital lesions

Cardiac

Diagnostic accuracy of combined coronary angiography and adenosine stress myocardial perfusion imaging using 320-detector computed tomography: pilot study

Breast

Diagnostic performances of shear wave elastography: which parameter to use in differential diagnosis of solid breast masses?